4.3 Editorial Material

Dual targeting of toll-like receptor 4 and angiotensin-converting enzyme 2: a proposed approach to SARS-CoV-2 treatment

Journal

FUTURE MICROBIOLOGY
Volume 16, Issue 4, Pages 205-210

Publisher

FUTURE MEDICINE LTD
DOI: 10.2217/fmb-2021-0018

Keywords

ACE2; angiotensin-converting enzyme 2; coronavirus; coronavirus disease 2019; COVID-19; SARS-CoV-2; TLR4; toll-like receptor

Categories

Funding

  1. Institute for Health and Sport, Victoria University, Melbourne Australia
  2. Victoria University
  3. College of Health and Biomedicine, Victoria University, Melbourne Australia
  4. Place Based Planetary Health from VU Research, Victoria University, Australia [PH098]

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available